<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cardiovascular</journal-id><journal-title-group><journal-title xml:lang="ru">Кардиоваскулярная терапия и профилактика</journal-title><trans-title-group xml:lang="en"><trans-title>Cardiovascular Therapy and Prevention</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1728-8800</issn><issn pub-type="epub">2619-0125</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1728-8800-2024-4037</article-id><article-id custom-type="edn" pub-id-type="custom">HXKJTD</article-id><article-id custom-type="elpub" pub-id-type="custom">cardiovascular-4037</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>СЕРДЕЧНАЯ НЕДОСТАТОЧНОСТЬ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>HEART FAILURE</subject></subj-group></article-categories><title-group><article-title>Связь сывороточных уровней белков теплового шока с выраженностью венозного застоя у пациентов с острой декомпенсацией сердечной недостаточности с сохраненной фракцией выброса</article-title><trans-title-group xml:lang="en"><trans-title>Interaction of serum heat shock proteins’ levels with the severity of venous congestion in patients with acute decompensated heart failure with preserved ejection fraction</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9305-6713</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тимофеев</surname><given-names>Ю. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Timofeev</surname><given-names>Yu. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Тимофеев Юрий Сергеевич — к.м.н., с.н.с. отдела фундаментальных и прикладных аспектов ожирения, руководитель лаборатории изучения биохимических маркеров риска хронических неинфекционных заболеваний им. Н.В. Перовой.</p><p>Москва</p></bio><bio xml:lang="en"><p>Yurii S. Timofeev.</p><p>Moscow</p></bio><email xlink:type="simple">YTimofeev@gnicpm.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0007-3933-5798</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Афаунова</surname><given-names>А. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Afaunova</surname><given-names>A. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Афаунова Алина Руслановна — врач-терапевт, аспирант.</p><p>Москва</p></bio><bio xml:lang="en"><p>Alina R. Afunova.</p><p>Moscow</p></bio><email xlink:type="simple">afaunovaa@list.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2812-959X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Иванова</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Ivanova</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Иванова Анна Александровна — м.н.с. отдела фундаментальных и прикладных аспектов ожирения.</p><p>Москва</p></bio><bio xml:lang="en"><p>Anna A. Ivanova.</p><p>Moscow</p></bio><email xlink:type="simple">annaivanova12121@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5321-676X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Веденикин</surname><given-names>Т. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Vedenikin</surname><given-names>T. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Веденикин Тимофей Юрьевич - зав. отделением анестезиологии-реанимации для больных кардиологического профиля.</p><p>Москва</p></bio><bio xml:lang="en"><p>Timofey Yu. Vedenikin.</p><p>Moscow</p></bio><email xlink:type="simple">annaivanova12121@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5384-3795</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Джиоева</surname><given-names>О. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Dzhioeva</surname><given-names>O. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Джиоева Ольга Николаевна — д.м.н., в.н.с. отдела фундаментальных и прикладных аспектов ожирения, директор Института профессионального образования, руководитель лаборатории кардиовизуализации, вегетативной регуляции и сомнологии.</p><p>Москва</p></bio><bio xml:lang="en"><p>Olga N. Dzhioeva.</p><p>Moscow</p></bio><email xlink:type="simple">dzhioevaon@gmail.com</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8665-9129</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Метельская</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Metelskaya</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Метельская Виктория Алексеевна — д.б.н., профессор, г.н.с. лаборатории изучения биохимических маркеров риска хронических неинфекционных заболеваний им. Н.В. Перовой.</p><p>Москва</p></bio><bio xml:lang="en"><p>Victoria A. Metelskaya.</p><p>Moscow</p></bio><email xlink:type="simple">VMetelskaya@gnicpm.ru</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6985-7131</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Покровская</surname><given-names>М. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Pokrovskaya</surname><given-names>M. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Покровская Мария Сергеевна — к.б.н., в.н.с., руководитель лаборатории "Банк биологического материала".</p><p>Москва</p></bio><bio xml:lang="en"><p>Maria S. Pokrovskaya.</p><p>Moscow</p></bio><email xlink:type="simple">MPokrovskaya@gnicpm.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4453-8430</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Драпкина</surname><given-names>О. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Drapkina</surname><given-names>O. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Драпкина Оксана Михайловна — д.м.н., профессор, академик РАН, директор.</p><p>Москва</p></bio><bio xml:lang="en"><p>Oksana M. Drapkina</p><p>Moscow</p></bio><email xlink:type="simple">drapkina@bk.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ "Национальный медицинский исследовательский центр терапии и профилактической медицины" Минздрава России</institution></aff><aff xml:lang="en"><institution>National Medical Research Center for Therapy and Preventive Medicine</institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ГБУЗ города Москвы "Городская клиническая больница им. В.В. Вересаева Департамента здравоохранения города Москвы"</institution></aff><aff xml:lang="en"><institution>Veresaev City Clinical Hospital</institution></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБУ "Национальный медицинский исследовательский центр терапии и профилактической медицины" Минздрава России; ФГБОУ ВО "Российский университет медицины" Минздрава России</institution></aff><aff xml:lang="en"><institution>National Medical Research Center for Therapy and Preventive Medicine; Russian University of Medicine</institution></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>ФГБУ "Национальный медицинский исследовательский центр терапии и профилактической медицины" Минздрава России; ФГБОУ ДПО "Российская медицинская академия непрерывного профессионального образования" Минздрава России</institution></aff><aff xml:lang="en"><institution>National Medical Research Center for Therapy and Preventive Medicine; Russian Medical Academy of Continuous Professional Education</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>29</day><month>05</month><year>2024</year></pub-date><volume>23</volume><issue>6</issue><fpage>4037</fpage><lpage>4037</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Тимофеев Ю.С., Афаунова А.Р., Иванова А.А., Веденикин Т.Ю., Джиоева О.Н., Метельская В.А., Покровская М.С., Драпкина О.М., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Тимофеев Ю.С., Афаунова А.Р., Иванова А.А., Веденикин Т.Ю., Джиоева О.Н., Метельская В.А., Покровская М.С., Драпкина О.М.</copyright-holder><copyright-holder xml:lang="en">Timofeev Y.S., Afaunova A.R., Ivanova A.A., Vedenikin T.Y., Dzhioeva O.N., Metelskaya V.A., Pokrovskaya M.S., Drapkina O.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://cardiovascular.elpub.ru/jour/article/view/4037">https://cardiovascular.elpub.ru/jour/article/view/4037</self-uri><abstract><sec><title>Цель</title><p>Цель. Анализ ассоциаций сывороточных уровней белков теплового шока (БТШ) — БТШ27, БТШ70 и кардиоваскулярного БТШ (квБТШ), с наличием острой декомпенсации и признаками венозного застоя у больных с сердечной недостаточностью с сохраненной фракцией выброса (СНсФВ).</p></sec><sec><title>Материал и методы</title><p>Материал и методы. Обследовано 80 больных с СНсФВ в возрасте 50-85 лет: 60 — с острой декомпенсацией и 20 — с компенсированной СНсФВ. Уровни БТШ анализировали иммуноферментным методом с использованием наборов реактивов AssayPro (США) и Cloud-­Clone (КНР/США) с детекцией на фотометре Multiskan FC.</p></sec><sec><title>Результаты</title><p>Результаты. Медианы уровней БТШ27, БТШ 70 и квБТШ у больных с острой декомпенсацией СНсФВ были статистически значимо выше, чем у больных с компенсированной СНсФВ. В группе больных с декомпенсированной СНсФВ с незначительным венозным застоем медианы БТШ27 (0,58 нг/мл) и квБТШ (905 пг/мл) статистически значимо ниже медиан в группе больных с умеренным или выраженным венозным застоем — 1,67 нг/мл и 1028 пг/мл, соответственно. Медианы БТШ27 и квБТШ у больных с количеством B-линий в одном сегменте ≥3 были статистически значимо выше медиан маркеров у больных с количеством B-линий &lt;3 более чем в 3,6 раз и 1,2 раза, соответственно.</p></sec><sec><title>Заключение</title><p>Заключение. Выявлена связь сывороточных концентраций БТШ27, БТШ70 и квБТШ с наличием острой декомпенсацией СНсФВ, при этом для БТШ27 и квБТШ показана взаимосвязь с выраженностью застойных явлений, оцениваемых по VExUS (Venous Excess UltraSound) и B-линиям.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim. To analyze the interactions between heat shock proteins (HSPs) (HSP27, HSP70 and cardiovascular HSP — cvHSP) serum levels and acute decompensated heart failure (HF) and signs of venous congestion in patients with preserved ejection fraction (HFpEF).</p></sec><sec><title>Material and methods</title><p>Material and methods. The study included 80 patients with HFpEF aged from 50 to 85 years: 60 with acute decompensated HF and 20 with stable HFpEF. HSP levels were estimated with the enzyme immunoassay method using AssayPro (USA) and Cloud-­Clone (PRC/USA) reagent kits with detection on a Multiskan FC photometer.</p></sec><sec><title>Results</title><p>Results. The medians of HSP27, HSP 70 and cvHSP in the acute decompensated HFpEF group were significantly higher than in the stable HFpEF group. In the decompensated HFpEF group with mild congestion, the medians of HSP27 (0,58 ng/ml) and cvHSP (905 pg/ml) were significantly lower than in the group of patients with moderate or severe congestion (1,67 ng/ml and 1028 pg/ml, respectively). The medians of HSP27 and cvHSP in the group with ≥3 B-lines in one lung segment were significantly higher than the medians in the group with &lt;3 B-lines by 3,6 times and 1,2 times, respectively.</p></sec><sec><title>Conclusion</title><p>Conclusion. Higher serum levels of HSP27, HSP70 and cvHSP are associated with the acute decompensated HFpEF. HSP27 and cvHSP levels are positively associated with the severity of congestion assessed by VExUS and B-lines.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>сердечная недостаточность с сохраненной фракцией выброса</kwd><kwd>трансторакальная эхокардиография</kwd><kwd>VExUS</kwd><kwd>белки теплового шока</kwd><kwd>БТШ27</kwd><kwd>БТШ70</kwd><kwd>квБТШ</kwd></kwd-group><kwd-group xml:lang="en"><kwd>heart failure with preserved ejection fraction</kwd><kwd>transthoracic echocardiography</kwd><kwd>VExUS</kwd><kwd>heat shock protein</kwd><kwd>HSP27</kwd><kwd>HSP70</kwd><kwd>cvHSP</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Поляков Д. С., Фомин И. В., Беленков Ю. Н. и др. Хроническая СН в Российской Федерации: что изменилось за 20 лет наблюдения? Результаты исследования ЭПОХА-ХСН. Кардиология. 2021;61(4):4-14. doi:10.18087/cardio.2021.4.n1628.</mixed-citation><mixed-citation xml:lang="en">Polyakov DS, Fomin IV, Belenkov YuN, et al. Chronic heart failure in the Russian Federation: what has changed over 20 years of follow-up? Results of the EPOCH-CHF study. Kardiologiia. 2021;61(4):4-14. (In Russ.) doi:10.18087/cardio.2021.4.n1628.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Драпкина О. М., Бойцов С. А., Омельяновский В. В. и др. Социально-экономический ущерб, обусловленный хронической СН, в Российской Федерации. Российский кардиологический журнал. 2021;26(6):4490. doi:10.15829/1560-4071-2021-4490.</mixed-citation><mixed-citation xml:lang="en">Drapkina OM, Boytsov SA, Omelyanovsky VV, et al. Socio-eco­nomic impact of heart failure in Russia. Russian Journal of Cardiology. 2021;26(6):4490. (In Russ.) doi:10.15829/1560-4071-2021-4490.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Хроническая сердечная недостаточность. Клинические рекомендации 2020. Российский кардиологический журнал. 2020;25(11): 4083. doi:10.15829/1560-4071-2020-4083.</mixed-citation><mixed-citation xml:lang="en">Clinical practice guidelines for Chronic heart failure. Rus­sian Journal of Cardiology. 2020;25(11):4083. (In Russ.) doi:10.15829/1560-4071-2020-4083.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Demi L, Wolfram F, Klersy C, et al. New International Guidelines and Consensus on the Use of Lung Ultrasound. J Ultrasound Med. 2023;42(2):309-44. doi:10.1002/jum.16088.</mixed-citation><mixed-citation xml:lang="en">Demi L, Wolfram F, Klersy C, et al. New International Guidelines and Consensus on the Use of Lung Ultrasound. J Ultrasound Med. 2023;42(2):309-44. doi:10.1002/jum.16088.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Beaubien-Souligny W, Rola P, Haycock K, et al. Quantifying systemic congestion with Point-­Of-­Care ultrasound: development of the venous excess ultrasound grading system. Ultrasound J. 2020;12(1):16. doi:10.1186/s13089-020-00163-w.</mixed-citation><mixed-citation xml:lang="en">Beaubien-­Souligny W, Rola P, Haycock K, et al. Quantifying systemic congestion with Point-­Of-­Care ultrasound: development of the venous excess ultrasound grading system. Ultrasound J. 2020;12(1):16. doi:10.1186/s13089-020-00163-w.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Кобалава Ж. Д., Асланова Р. Ш., Сафа­рова А. Ф., Вацик-­Городецкая М. В. Прикроватная ультразвуковая оценка венозного застоя по протоколу VExUS при хронической сердечной недостаточности: клинические ассоциации и прогностическое значение. Рациональная Фармакотерапия в Кардиологии. 2023;19(4):341-9. doi:10.20996/1819-6446-2023-2921.</mixed-citation><mixed-citation xml:lang="en">Kobalava ZhD, Aslanova RSh, Safarova AF, Vatsik-­Gorodetskaya MV. Bedside ultrasound assessment of venous congestion by VExUS protocol in heart failure: clinical associations and prognostic value. Rational Pharmacotherapy in Cardiology. 2023; 19(4):341-9. (In Russ.) doi:10.20996/1819-6446-2023-2921.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Torres-Arrese M, Mata-Martínez A, Luordo-Tedesco D, et al. Usefulness of Systemic Venous Ultrasound Protocols in the Prognosis of Heart Failure Patients: Results from a Prospective Multicentric Study. J Clin Med. 2023;12(4):1281. doi:10.3390/jcm12041281.</mixed-citation><mixed-citation xml:lang="en">Torres-Arrese M, Mata-Martínez A, Luordo-Tedesco D, et al. Usefulness of Systemic Venous Ultrasound Protocols in the Prognosis of Heart Failure Patients: Results from a Prospective Multicentric Study. J Clin Med. 2023;12(4):1281. doi:10.3390/jcm12041281.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Zhou B, Tian R. Mitochondrial dysfunction in pathophysiology of heart failure. J Clin Invest. 2018;128(9):3716-26. doi:10.1172/JCI120849.</mixed-citation><mixed-citation xml:lang="en">Zhou B, Tian R. Mitochondrial dysfunction in pathophysiology of heart failure. J Clin Invest. 2018;128(9):3716-26. doi:10.1172/JCI120849.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Drapkina OM. The specific features of synthesis of heat shock proteins in patients with postinfarct cardiosclerosis. Klin Med (Mosk). 2004;82(9):25-8.</mixed-citation><mixed-citation xml:lang="en">Drapkina OM. The specific features of synthesis of heat shock proteins in patients with postinfarct cardiosclerosis. Klin Med (Mosk). 2004;82(9):25-8.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Ганковская Л. В., Понасенко О. А., Свитич О. А. Роль белка теплового шока 70 в патогенезе сердечно-­сосудистой патологии. Медицинская иммунология. 2019;21(2):201-8. doi:10.15789/1563-0625-2019-2-201-208.</mixed-citation><mixed-citation xml:lang="en">Gankovskaya LV, Ponasenko OA, Svitich OA. Role of heat shock protein 70 in pathogenesis of cardiovascular pathology. Medical Im­munology. 2019;21(2):201-8. (In Russ.) doi:10.15789/1563-0625-2019-2-201-208.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Shan Q, Ma F, Wei J, et al. Physiological Functions of Heat Shock Proteins. Curr Protein Pept Sci. 2020;21(8):751-60. doi:10.2174/1389203720666191111113726.</mixed-citation><mixed-citation xml:lang="en">Shan Q, Ma F, Wei J, et al. Physiological Functions of Heat Shock Proteins. Curr Protein Pept Sci. 2020;21(8):751-60. doi:10.2174/1389203720666191111113726.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Dubrez L, Causse S, Borges Bonan N, et al. Heat-shock proteins: chaperoning DNA repair. Oncogene. 2020;39(3):516-29. doi:10.1038/s41388-019-1016-y.</mixed-citation><mixed-citation xml:lang="en">Dubrez L, Causse S, Borges Bonan N, et al. Heat-shock proteins: chaperoning DNA repair. Oncogene. 2020;39(3):516-29. doi:10.1038/s41388-019-1016-y.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kovács D, Kovács M, Ahmed S, et al. Functional diversification of heat shock factors. Biol Futur. 2022;73(4):427-39. doi:10.1007/s42977-022-00138-z.</mixed-citation><mixed-citation xml:lang="en">Kovács D, Kovács M, Ahmed S, et al. Functional diversification of heat shock factors. Biol Futur. 2022;73(4):427-39. doi:10.1007/s42977-022-00138-z.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Kurop MK, Huyen CM, Kelly JH, et al. The heat shock response and small molecule regulators. Eur J Med Chem. 2021;226: 113846. doi:10.1016/j.ejmech.2021.113846.</mixed-citation><mixed-citation xml:lang="en">Kurop MK, Huyen CM, Kelly JH, et al. The heat shock response and small molecule regulators. Eur J Med Chem. 2021;226: 113846. doi:10.1016/j.ejmech.2021.113846.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Muranova LK, Shatov VM, Gusev NB. Role of Small Heat Shock Proteins in the Remodeling of Actin Microfilaments. Biochemistry (Mosc). 2022;87(8):800-11. doi:10.1134/S0006297922080119.</mixed-citation><mixed-citation xml:lang="en">Muranova LK, Shatov VM, Gusev NB. Role of Small Heat Shock Proteins in the Remodeling of Actin Microfilaments. Biochemistry (Mosc). 2022;87(8):800-11. doi:10.1134/S0006297922080119.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Wu T, Mu Y, Bogomolovas J, et al. HSPB7 is indispensable for heart development by modulating actin filament assembly. Proc Natl Acad Sci USA. 2017;114(45):11956-61. doi:10.1073/pnas.1713763114.</mixed-citation><mixed-citation xml:lang="en">Wu T, Mu Y, Bogomolovas J, et al. HSPB7 is indispensable for heart development by modulating actin filament assembly. Proc Natl Acad Sci USA. 2017;114(45):11956-61. doi:10.1073/pnas.1713763114.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Traxler D, Lainscak M, Simader E, et al. Heat shock protein 27 acts as a predictor of prognosis in chronic heart failure patients. Clin Chim Acta. 2017;473:127-32. doi:10.1016/j.cca.2017.08.028.</mixed-citation><mixed-citation xml:lang="en">Traxler D, Lainscak M, Simader E, et al. Heat shock protein 27 acts as a predictor of prognosis in chronic heart failure patients. Clin Chim Acta. 2017;473:127-32. doi:10.1016/j.cca.2017.08.028.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Duan Y, Tang H, Mitchell-­Silbaugh K, et al. Heat Shock Protein 60 in Cardiovascular Physiology and Diseases. Front Mol Biosci. 2020;7:73. doi:10.3389/fmolb.2020.00073.</mixed-citation><mixed-citation xml:lang="en">Duan Y, Tang H, Mitchell-­Silbaugh K, et al. Heat Shock Protein 60 in Cardiovascular Physiology and Diseases. Front Mol Biosci. 2020;7:73. doi:10.3389/fmolb.2020.00073.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Котова Ю. А., Зуйкова А. А. Изучение маркеров повреждения эндотелия, окислительного и клеточного стресса у больных ИБС и сопутствующим ожирением. Вестник новых медицинских технологий. 2021;28(2):25-8. doi:10.24412/1609-2163-2021-2-25-28.</mixed-citation><mixed-citation xml:lang="en">Kotova YuA, Zuikova AA. Study of markers of endothelial damage, oxidative and cellular stress in patients with IHD and concomitant obesity. Journal of New Medical Technologies. 2021;28(2):25-8. (In Russ.) doi:10.24412/1609-2163-2021-2-25-28.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">McDonagh T, Metra M. 2021 Рекомендации ESC по диагностике и лечению острой и хронической сердечной недостаточности. Российский кардиологический журнал. 2023;28(1):5168. doi:10.10.15829/1560-4071-2023-5168.</mixed-citation><mixed-citation xml:lang="en">McDonagh T, Metra M. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Russian Journal of Cardiology. 2023;28(1):5168. (In Russ.) doi:10.10.15829/1560-4071-2023-5168.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Jaroszyński A, Jaroszyńska A, Zaborowski T, et al. Serum heat shock protein 27 levels predict cardiac mortality in hemodialysis patients. BMC Nephrol. 2018;19(1):359. doi:10.1186/s12882-018-1157-1.</mixed-citation><mixed-citation xml:lang="en">Jaroszyński A, Jaroszyńska A, Zaborowski T, et al. Serum heat shock protein 27 levels predict cardiac mortality in hemodialysis patients. BMC Nephrol. 2018;19(1):359. doi:10.1186/s12882-018-1157-1.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Liu S, Iskandar R, Chen W, et al. Soluble Glycoprotein 130 and Heat Shock Protein 27 as Novel Candidate Biomarkers of Chronic Heart Failure with Preserved Ejection Fraction. Heart Lung Circ. 2016;25(10):1000-6. doi:10.1016/j.hlc.2016.02.011.</mixed-citation><mixed-citation xml:lang="en">Liu S, Iskandar R, Chen W, et al. Soluble Glycoprotein 130 and Heat Shock Protein 27 as Novel Candidate Biomarkers of Chronic Heart Failure with Preserved Ejection Fraction. Heart Lung Circ. 2016;25(10):1000-6. doi:10.1016/j.hlc.2016.02.011.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Li Z, Song Y, Xing R, at al. Heat shock protein 70 acts as a potential biomarker for early diagnosis of heart failure. PLoS One. 2013;8(7):e67964. doi:10.1371/journal.pone.0067964.</mixed-citation><mixed-citation xml:lang="en">Li Z, Song Y, Xing R, at al. Heat shock protein 70 acts as a potential biomarker for early diagnosis of heart failure. PLoS One. 2013;8(7):e67964. doi:10.1371/journal.pone.0067964.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Gombos T, Förhécz Z, Pozsonyi Z, et al. Interaction of serum 70-kDa heat shock protein levels and HspA1B (+1267) gene polymorphism with disease severity in patients with chronic heart failure. Cell Stress Chaperones. 2008;13(2):199-206. doi:10.1007/s12192-007-0001-5.</mixed-citation><mixed-citation xml:lang="en">Gombos T, Förhécz Z, Pozsonyi Z, et al. Interaction of serum 70-kDa heat shock protein levels and HspA1B (+1267) gene polymorphism with disease severity in patients with chronic heart failure. Cell Stress Chaperones. 2008;13(2):199-206. doi:10.1007/s12192-007-0001-5.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Rüdebusch J, Benkner A, Poesch A, at al. Dynamic adaptation of myocardial proteome during heart failure development. PLoS One. 2017;12(10):e0185915. doi:10.1371/journal.pone.0185915.</mixed-citation><mixed-citation xml:lang="en">Rüdebusch J, Benkner A, Poesch A, at al. Dynamic adaptation of myocardial proteome during heart failure development. PLoS One. 2017;12(10):e0185915. doi:10.1371/journal.pone.0185915.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
